期刊文献+

吡咯烷二硫代甲酸铵干预NF—κB p65核转位抑制尿毒症大鼠主动脉钙化 被引量:1

Pyrrolidine - dithio - carbamate ammonium counteracts high - phosphate - induced aortic calcification by inhibiting p65 nuclear translocation in uremic rats
原文传递
导出
摘要 目的探讨NF.KB抑制剂吡咯烷二硫代甲酸铵(PDTC)对尿毒症大鼠主动脉钙化的干预作用及相关机制。方法16只雄性sD大鼠被随机分为尿毒症模型组及PDTC干预组,均予0.75%腺嘌呤及高磷(1%)饮食,制备尿毒症动脉钙化模型,干预组同时腹腔注射PDTC100mg·kg^-1·d^-1。另取8只匹配大鼠作为健康对照。8周后处死大鼠,HE及yon Kossa染色观察腹主动脉病理改变及钙化情况,免疫组织化学方法检测骨调素(OPN)、核心结合因子α1(Cbfα1)在主动脉的定位与表达,Western印迹检测主动脉NF-κB总p65与细胞核内P—p65、OPN、Cbfα1等蛋白表达量。结果造模4周及8周,尿毒症组、PDTC组大鼠血清BUN、Scr、血磷、钙磷乘积均显著高于对照组(均P<0.01),但此两组间差异无统计学意义(P,0.05);造模8周,尿毒症组和PDTC组大鼠主动脉明显增厚及中膜钙化,PDTC组程度较轻(P<0.05),免疫组化显示主动脉内皮下、中膜及外膜均有OPN、Cbfα1表达,PDTC组表达量较少(均P<0.05);Western印迹显示PDTC组主动脉NF—κB总p65、核p-p65、OPN、Cbfα1表达均较尿毒症组下降(均P<0.01),且Cbfcd表达与p65、核P—p65表达呈正相关(r=O.707,P<0.01;r=O.507,P<0.01)。结论PDTC可阻断NF-κBp65核转位,抑制尿毒症大鼠主动脉Cbfcd表达,减轻血管钙化。 Objective To investigate the effects of pyrrolidine-dithio-carbamate ammonium (PDTC) on high-phosphate-induced vascular calcification in uremic rats. Methods Eight-week-old SD rats were pair-fed with standard chow containing 1.2% calcium and 0.6% phosphorus for the control group (n=8) or 0.75% adenine, 1.2% calcium, and 1% phosphorus for the chronic renal failure(CRF) group (n=8) or PDTC group (intraperitoneal injection, 100 mg·kg^-1·d^-1, n=8) for 8 weeks. The abdominal aortas were excised for Western blotting and immunostaining assay of NF-κB p65, osteopontin (OPN) and core binding factor αl(Cbfctl) protein. Results Serum urea nitrogen, creatinine, inorganic phosphate, calcium-phosphorus product increased significantly in CRF group and PDTC group after 4 weeks and 8 weeks (all P 〈 0.01), although no differences were found between the latter two groups. After 8 weeks, aortic calcification was found in these two groups, immunostaining assay revealed OPN and Cbfcd expressed in aortic intima, media and adventitia, and Western blottinganalysis showed that total NF- κB p65, nuclear phosphorylated- p65 (p- p65), OPN and Cbfcil expressions were significantly higher than those in control group (all P 〈0.01). The expression of total p65 and p- p65 was positively correlated with Cbfo^l(r=0.707, P 〈 0.01; r=0.507, P 〈0.01). Conclusion PDTC alleviates inorganic phosphate- induced aortic calcification significantly by inhibiting the nuclear translocation of NF-κB p65 and the expression of Cbfal.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2014年第8期614-618,共5页 Chinese Journal of Nephrology
基金 国家自然科学基金(31270791,30800529) 天津市科委应用基础及前沿计划(10JCYBJC11700) 天津市卫生局重点攻关课题(11KGl32)
关键词 尿毒症 NF-κB 血管钙化 吡咯烷二硫代甲酸铵 Uremia NF- KB Vascular calcification Pyrrolidine- dithio- carbamateammonium
  • 相关文献

参考文献4

二级参考文献29

  • 1张萍,陈江华,蒋华,王慧萍,金娟.尿毒症患者血管中膜钙化和骨特异性蛋白的表达[J].中华肾脏病杂志,2005,21(2):69-71. 被引量:11
  • 2孙艳玲,林洪丽,吴泰华,王楠,谢华,刘越坚.ERK1/2 MAPK通路在TIMP-1抑制高糖诱导的大鼠肾小球系膜细胞凋亡中的作用[J].中华肾脏病杂志,2006,22(9):554-558. 被引量:8
  • 3Derici U, El Nahas AM. Vascular calcifications in uremia: old concepts and new insights. Semin Dial, 2006, 19: 60- 68.
  • 4Moe SM, O'Neill KD, Duan D, et al. Medial artery calcifieation in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int, 2002, 61: 638-647.
  • 5Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab, 2004. 286: E686-E696.
  • 6Lin H, Chen X, Wang J, et al. Inhibition of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1. Kidney Int, 2002, 62: 60-69.
  • 7Cozzolino M, Staniforth ME, Liapis H, et al. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int, 2003, 64: 1653-1661.
  • 8Tamagaki K, Yuan Q, Ohkawa H, et al. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant, 2006, 21: 651-659.
  • 9Yokozawa T, Oura H, Ienaga K, et al. Comparison of renal effects of creatinine, creatol and methylguanidine in rats with adenine-induced chronic renal failure. Nephron, 1993, 64: 424-428.
  • 10Hayden MR, Tyagi SC, Kolb L, et al. Vascular ossification- calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging the of sodium thiosulfate. Cardiovasc Diabetol, 2005, 4: 4.

共引文献29

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部